Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Murphy

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Neurology|February 1, 1997
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigatorsE L Murphy, J Fridey, J W Smith, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 21, 2014
Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safetyA B Diarra, B Kouriba, A Guindo, et al.
Transfusion|November 1, 1995
The Retrovirus Epidemiology Donor Study (REDS): rationale and methodsT F Zuck, R A Thomson, G B Schreiber, et al.
Neurology|September 10, 2009
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathyH H Biswas, J W Engstrom, Z Kaidarova, et al.
International Journal of Cancer|May 14, 1998
Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French GuianaS Plancoulaine, R P Buigues, E L Murphy, et al.
JAMA|April 3, 1996
Demographic determinants of hepatitis C virus seroprevalence among blood donorsE L Murphy, S Bryzman, A E Williams, et al.
Vox Sanguinis|December 22, 2016
Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithmN H Roubinian, J E Hendrickson, D J Triulzi, et al.
The Journal of Infectious Diseases|December 12, 1997
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)E L Murphy, S M Bryzman, S A Glynn, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study GroupJ E Kaplan, R F Khabbaz, E L Murphy, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Neurology|February 1, 1997
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigatorsE L Murphy, J Fridey, J W Smith, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 21, 2014
Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safetyA B Diarra, B Kouriba, A Guindo, et al.
Transfusion|November 1, 1995
The Retrovirus Epidemiology Donor Study (REDS): rationale and methodsT F Zuck, R A Thomson, G B Schreiber, et al.
Neurology|September 10, 2009
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathyH H Biswas, J W Engstrom, Z Kaidarova, et al.
International Journal of Cancer|May 14, 1998
Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French GuianaS Plancoulaine, R P Buigues, E L Murphy, et al.
JAMA|April 3, 1996
Demographic determinants of hepatitis C virus seroprevalence among blood donorsE L Murphy, S Bryzman, A E Williams, et al.
Vox Sanguinis|December 22, 2016
Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithmN H Roubinian, J E Hendrickson, D J Triulzi, et al.
The Journal of Infectious Diseases|December 12, 1997
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)E L Murphy, S M Bryzman, S A Glynn, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study GroupJ E Kaplan, R F Khabbaz, E L Murphy, et al.
Pageof 11